Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 20086542)

1.

Ketorolac use in the national football league: prevalence, efficacy, and adverse events.

Tokish JM, Powell ET, Schlegel TF, Hawkins RJ.

Phys Sportsmed. 2002 Sep;30(9):19-24. doi: 10.3810/psm.2002.09.428.

PMID:
20086542
2.

Concussion in the national football league: an overview for neurologists.

Casson IR, Pellman EJ, Viano DC.

Neurol Clin. 2008 Feb;26(1):217-41; x-xi. doi: 10.1016/j.ncl.2007.11.005. Review.

PMID:
18295092
3.

Concussion in professional football: epidemiological features of game injuries and review of the literature--part 3.

Pellman EJ, Powell JW, Viano DC, Casson IR, Tucker AM, Feuer H, Lovell M, Waeckerle JF, Robertson DW.

Neurosurgery. 2004 Jan;54(1):81-94; discussion 94-6. Review.

PMID:
14683544
4.

Science of rugby league football: a review.

Gabbett TJ.

J Sports Sci. 2005 Sep;23(9):961-76. Review.

PMID:
16195048
5.
6.

Ketorolac, an injectable nonnarcotic analgesic.

Litvak KM, McEvoy GK.

Clin Pharm. 1990 Dec;9(12):921-35. Review.

PMID:
2292174
7.

Applied physiology of rugby league.

Gabbett T, King T, Jenkins D.

Sports Med. 2008;38(2):119-38. Review.

PMID:
18201115
8.

Early cardiovascular mortality in professional football players: fact or fiction?

Selden MA, Helzberg JH, Waeckerle JF.

Am J Med. 2009 Sep;122(9):811-4. doi: 10.1016/j.amjmed.2009.03.027. Review.

PMID:
19699372
9.

Review of cardiometabolic risk factors among current professional football and professional baseball players.

Helzberg JH, Camilo J, Waeckerle JF, O'Keefe JH.

Phys Sportsmed. 2010 Oct;38(3):77-83. doi: 10.3810/psm.2010.10.1811. Review.

PMID:
20959699
10.

An update on the use of ophthalmic ketorolac tromethamine 0.4%.

Perry HD, Donnenfeld ED.

Expert Opin Pharmacother. 2006 Jan;7(1):99-107. Review.

PMID:
16370927
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk